Search
Now showing items 1-3 of 3
Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
(The New England Journal of Medicine, 2014)
Background
Cryptococcal meningitis accounts for 20 to 25% of acquired immunodeficiency
syndrome–related deaths in Africa. Antiretroviral therapy (ART) is essential for
survival; however, the question of when ART should ...
Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
(Massachusetts Medical Society, 2014)
Background
Cryptococcal meningitis accounts for 20 to 25% of acquired immunodeficiency
syndrome–related deaths in Africa. Antiretroviral therapy (ART) is essential for
survival; however, the question of when ART should ...
“You would not be in a hurry to go back home”: Patients’ willingness to participate in HIV/AIDS clinical trials at a clinical and research facility in Kampala, Uganda
(BMC, 2020)
Background: Few studies have examined factors associated with willingness of people living with HIV (PLHIV) to
participate in HIV treatment clinical trials in Sub-Saharan Africa. We assessed the factors associated with ...